USPTO Examiner BERTRAM ERIC D - Art Unit 3792

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17137907METHOD AND APPARATUS FOR CLINICAL EFFECTS-BASED TARGETING OF NEUROSTIMULATIONDecember 2020August 2022Allow1910NoNo
17135425Pressure/Flow Characteristic Modification of a Centrifugal Pump in a Ventricular Assist DeviceDecember 2020December 2022Allow2420NoNo
17124181CARDIAC ENERGY HARVESTING DEVICE AND METHODS OF USEDecember 2020May 2023Allow2911NoNo
17115225SYSTEM, METHOD, AND APPARATUS FOR VISUALIZING CARDIAC TIMING INFORMATION USING ANIMATIONSDecember 2020October 2022Allow2220NoNo
16972568HEART SUPPORT NET AND IMPLANTABLE CARDIOVERTER DEFIBRILLATORDecember 2020September 2021Allow910YesNo
17109305COCHLEAR IMPLANT STIMULATION CALIBRATIONDecember 2020June 2022Allow1800NoNo
17106152IMPLANTABLE ELECTRICAL LEADS AND ASSOCIATED DELIVERY SYSTEMSNovember 2020January 2023Allow2611YesNo
17105603IMPLANTABLE MEDICAL DEVICES FOR MULTI-CHAMBER PACINGNovember 2020August 2023Abandon3321YesNo
17098676ACCESSORY-BASED STORAGE FOR USE WITH A MEDICAL DEVICENovember 2020March 2023Allow2820YesNo
17096773HINGED LEAD FIXATION DEVICES FOR SECURING A LEAD TO A CRANIUMNovember 2020June 2022Allow1920NoNo
17093464REFLECTOR MARKERS AND SYSTEMS AND METHODS FOR IDENTIFYING AND LOCATING THEMNovember 2020May 2022Allow1910NoNo
17086794BURR HOLE DEVICE INSERTION TOOLNovember 2020July 2023Allow3230YesNo
17085780IMPLANT MAGNET SYSTEMOctober 2020April 2021Allow520YesNo
17083774PERCUTANEOUS NERVE EVALUATION FOR SACRAL NEUROMODULATIONOctober 2020August 2022Allow2200NoNo
17076450CARDIAC NET HAVING AT LEAST ONE ELECTRODEOctober 2020May 2022Allow1820YesNo
17075557Transfer of Cardiac Arrest Data Between DefibrillatorsOctober 2020March 2022Allow1610YesNo
17046718CARDIAC IMPLANTATION DEVICE AND PACING SYSTEMOctober 2020September 2023Allow3550NoNo
17040766AURICULAR NERVE FIELD STIMULATION DEVICESeptember 2020February 2022Allow1710NoNo
17020201IMPLANTABLE STIMULATING ASSEMBLY WITH LIMITED COMPONENTSSeptember 2020June 2023Allow3321YesYes
17016936TOOLS AND SYSTEMS FOR IMPLANTING AND/OR RETRIEVING A LEADLESS CARDIAC PACING DEVICE WITH HELIX FIXATIONSeptember 2020August 2022Allow2310NoNo
16996219PUMP TO MOTOR CONNECTION SYSTEMAugust 2020May 2022Allow2120YesNo
16987052DEFIBRILLATION CATHETER SYSTEM, DEFIBRILLATION POWER SUPPLY DEVICE AND METHOD FOR CONTROLLING DEFIBRILLATION POWER SUPPLY DEVICEAugust 2020February 2023Allow3021YesNo
16986591DEFIBRILLATION CATHETER SYSTEM, DEFIBRILLATION POWER SUPPLY DEVICE AND METHOD FOR CONTROLLING DEFIBRILLATION POWER SUPPLY DEVICEAugust 2020February 2023Allow3021YesNo
16943351APPARATUS AND METHOD FOR TREATING MULTIPLE TUMORS IN PATIENTS WITH METASTATIC DISEASE BY ELECTRIC FIELDSJuly 2020December 2022Allow2830NoNo
16931844Systems, Devices, Components and Methods for Detecting the Locations of Sources of Cardiac Rhythm Disorders in a Patient's HeartJuly 2020April 2022Allow2110YesNo
16929434DYNAMIC STIMULUS RESOLUTION ADAPTIONJuly 2020June 2022Allow2321YesNo
16772795FIXING DEVICE OF WIRELESS CHARGER AND WIRELESS CHARGING DEVICEJune 2020October 2022Allow2820NoNo
16890668EXTRAVASCULAR IMPLANTABLE ELECTRICAL LEAD HAVING UNDULATING CONFIGURATIONJune 2020July 2023Allow3721YesNo
16888462IMPLANTABLE ELECTRICAL LEADS AND ASSOCIATED DELIVERY SYSTEMSMay 2020February 2023Allow3221YesNo
16767969Slotted Stiffening Member for Facilitating an Insertion of an Electrode Lead into a Cochlea of a PatientMay 2020May 2022Allow2320YesNo
16874571MULTI-FUNCTION PORTABLE AUTOMATED EXTERNAL DEFIBRILLATORMay 2020December 2021Allow1911YesNo
16870455APPARATUS, SYSTEM, AND METHOD FOR SELECTIVE STIMULATIONMay 2020February 2022Allow2121YesNo
16864317FORAMINAL LIGAMENT ANCHOR FOR APPLICATION IN DRG THERAPYMay 2020October 2022Allow2911NoNo
16862782SYSTEM AND METHOD FOR DETERMINING INCONTINENCE DEVICE REPLACEMENT INTERVALApril 2020August 2022Allow2830NoNo
16759800Inductive Link Coupling Based On Relative Angular Position Determination for Medical Implant SystemsApril 2020November 2021Allow1800NoNo
16857747ELECTRICAL STIMULATION DEVICE WITH MINIMALLY INVASIVE DELIVERYApril 2020February 2023Allow3331YesNo
16858452LEAD FOR THE TEMPORARY STIMULATION OF A PERIPHERAL NERVEApril 2020May 2022Allow2511YesNo
16758216EXTERNAL SYSTEM FOR IMPLANTED MEDICAL DEVICESApril 2020December 2022Allow3131YesNo
16841131FIXATION SYSTEM FOR AN IMPLANTABLE MEDICAL DEVICEApril 2020August 2023Abandon4131YesNo
16841417PASSIVE TAGS, AND SYSTEMS AND METHODS FOR USING THEMApril 2020February 2022Allow2210NoNo
16838865BIOSTIMULATOR TRANSPORT SYSTEM HAVING WELDLESS BEARING RETAINERApril 2020July 2022Allow2711YesNo
16835180Peripheral Nerve Electrode for Neural Recording and StimulationMarch 2020November 2022Allow3221YesNo
16648031FLEXIBLE IMPLANTABLE TISSUE STIMULATOR AND METHODS OF MAKING AND USING SAMEMarch 2020May 2022Allow2631NoNo
16820787LEADLESS CARDIAC PACEMAKER DEVICE CONFIGURED TO PROVIDE HIS BUNDLE PACINGMarch 2020January 2023Allow3431NoNo
16646002HEARING PROSTHESISMarch 2020September 2022Allow3021YesNo
16811189In-Package IMD Configuration Management, Self-Test, and Programming Support System for Acoustic Communication Enabled ImplantsMarch 2020May 2022Allow2720NoNo
16804500CATHETER AND CATHETER SYSTEM FOR ELECTRICAL NEUROMODULATIONFebruary 2020June 2022Abandon2811NoNo
16802660INTRAVASCULAR BLOOD PUMPFebruary 2020December 2022Allow3421YesNo
16796058IMPLANT MAGNET SYSTEMFebruary 2020July 2022Abandon2921YesNo
16640042SYSTEM FOR ELECTRICAL STIMULATION OF NERVESFebruary 2020July 2022Abandon2920YesNo
16791781LEAD INTRODUCERS AND SYSTEMS AND METHODS INCLUDING THE LEAD INTRODUCERSFebruary 2020October 2022Allow3221YesNo
16791785BIOSTIMULATOR HAVING RESILIENT SCAFFOLDFebruary 2020March 2022Allow2531YesNo
16780083LEAD-IN-LEAD SYSTEMS AND METHODS FOR CARDIAC THERAPYFebruary 2020April 2022Abandon2621NoNo
16774429Housing for an Implantable Medical DeviceJanuary 2020December 2021Allow2221NoNo
16634598IMPLANTABLE ELECTRODE COUPLED TO AN OPTOELECTRONIC DEVICEJanuary 2020March 2021Allow1410NoNo
16773428CARTRIDGE FOR AN ELECTRODE ARRAY INSERTION DEVICEJanuary 2020January 2023Abandon3621NoYes
16773599DEVICES, SYSTEMS, AND METHODS FOR CARDIAC RESYNCHRONIZATION THERAPYJanuary 2020November 2021Allow2111NoNo
16752163MEDICAL LEAD FOR TREATING OBSTRUCTIVE SLEEP APNEA (OSA) WITH ELECTRICAL STIMULATIONJanuary 2020November 2021Allow2111NoNo
16748621WCD SYSTEM PRIORITIZATION OF ALERTS BASED ON SEVERITY AND/OR REQUIRED TIMELINESS OF USER RESPONSEJanuary 2020December 2021Allow2311NoNo
16746536BLOOD VESSEL CONSTRICTION DEVICEJanuary 2020December 2022Abandon3510NoNo
16742167METHOD OF USING MULTICHANNEL STIMULATION SYSTEM FOR REGENERATING DAMAGED CORNEAL NERVESJanuary 2020June 2020Allow510NoNo
16734202LASER ABLATION CATHETERS HAVING EXPANDED DISTAL TIP WINDOWS FOR EFFICIENT TISSUE ABLATIONJanuary 2020November 2021Allow2310NoNo
16726283WEARABLE MEDICAL DEVICE RESPONSE MECHANISMS AND METHODS OF USEDecember 2019November 2022Allow3531NoNo
16724312EXTRACTOR FOR REMOVING A LEAD FROM A PATIENTDecember 2019January 2023Allow3711NoNo
16724254Systems, Devices, Components and Methods for Detecting the Locations of Sources of Cardiac Rhythm Disorders in a Patient?s Hea22December 2019March 2022Allow2711YesNo
16723752STEREOTACTIC FRAMEDecember 2019December 2021Allow2411NoNo
16720030ATRIAL TRACKING IN AN INTRACARDIAC VENTRICULAR PACEMAKERDecember 2019December 2021Allow2411YesNo
16708286REFLECTOR MARKERS AND SYSTEMS AND METHODS FOR IDENTIFYING AND LOCATING THEMDecember 2019August 2021Allow2011NoNo
16705563DEVICE AND METHOD MODULATING NERVE OF A PATIENT BY PROVIDING ELECTRICAL STIMULATIONDecember 2019July 2021Allow1911NoNo
16497873COMPOUND ELECTRODE-TYPE INTRACARDIAC DEFIBRILLATION CATHETER AND COMPOUND ELECTRODE-TYPE INTRACARDIAC DEFIBRILLATION CATHETER UNITDecember 2019October 2022Allow3720YesNo
16698825EPIDERMAL SENSOR SYSTEM AND PROCESSNovember 2019December 2021Allow2511NoNo
16691863HEADSETS FOR POSITIONING ELECTRONIC DEVICESNovember 2019January 2023Allow3841YesNo
16610553Delivery Device With Tethering For Implantable Medical DeviceNovember 2019April 2021Allow1800NoNo
16670978SELECTIVE HIGH FREQUENCY SPINAL CORD MODULATION FOR INHIBITING PAIN, INCLUDING CEPHALIC AND/OR TOTAL BODY PAIN WITH REDUCED SIDE EFFECTS, AND ASSOCIATED SYSTEMS AND METHODSOctober 2019November 2021Allow2511YesNo
16669419MEGAHERTZ COMPRESSION OF NANOSECOND PULSE BURSTSOctober 2019February 2022Allow2721YesNo
16667283FISTULA FORMATION DEVICES AND METHODS THEREFOROctober 2019September 2021Allow2220NoNo
16660471METHOD, DEVICES AND SYSTEMS FOR SENSOR WITH REMOVABLE NODESOctober 2019November 2021Allow2421YesNo
16654052ATRIAL TRACKING IN AN INTRACARDIAC VENTRICULAR PACEMAKEROctober 2019February 2022Allow2830YesNo
16654948HEART SIGNAL WAVEFORM PROCESSING SYSTEM AND METHODOctober 2019July 2021Allow2140NoNo
16601119HIS LEAD WITH EXTENSIBLE ELECTRODE AND REPOSITIONING FEATURESOctober 2019July 2022Allow3321NoNo
16597620IMPLANTABLE NEURAL STIMULATOR WITH MODE SWITCHINGOctober 2019February 2022Allow2921YesNo
16590930UNIVERSAL POWER SUPPLY FOR A FUNCTIONAL CRANIAL IMPLANTOctober 2019October 2021Allow2521YesNo
16499106POLYMER-BASED OPTOELECTRONIC INTERFACE AND METHODS FOR ITS MANUFACTURESeptember 2019May 2022Allow3130NoNo
16579579SEALS FOR LEAD BORES OF IMPLANTABLE MEDICAL DEVICESSeptember 2019April 2023Allow4321YesNo
16568768DEVICE AND METHOD FOR THE GEOMETRIC DETERMINATION OF ELECTRICAL DIPOLE DENSITIES ON THE CARDIAC WALLSeptember 2019May 2021Allow2010NoNo
16562349METHOD FOR TREATING MALE SEXUAL DYSFUNCTION BY USING UNDERPANTS COMPRISING FAR-INFRARED FIBERSSeptember 2019January 2021Allow1610NoNo
16537917System and Method for Distinguishing a Cardiac Event From Noise in an Electrocardiogram (ECG) SignalAugust 2019July 2021Allow2310NoNo
16534615HEART RATE DETERMINATION BASED ON VAD CURRENT WAVEFORMAugust 2019June 2021Allow2310NoNo
16519282ONSET-MITIGATING HIGH-FREQUENCY NERVE BLOCKJuly 2019April 2021Abandon2140YesNo
16453917STIMULATION APPARATUSJune 2019July 2022Allow3640NoNo
16442845HEART RATE ESTIMATION APPARATUS WITH STATE SEQUENCE OPTIMIZATIONJune 2019May 2021Allow2320YesNo
16434013Apparatus And Method For Intravascular Catheter Navigation Using The Electrical Conduction System Of The Heart And Control ElectrodesJune 2019May 2021Allow2321NoNo
16413836APPARATUS FOR MONITORING A CARDIAC RHYTHM DURING CPRMay 2019November 2021Allow3040YesNo
16405504VAPORIZATION ELECTRODES AND ELECTROSURGICAL DEVICES EQUIPPED THEREWITHMay 2019June 2021Allow2610NoNo
16398936ELECTRICAL STIMULATION APPARATUS AND METHOD FOR CONTROLLING SAMEApril 2019May 2022Allow3740YesNo
16399003CURRENT MONITORING APPARATUS AND ELECTRICAL STIMULATION APPARATUS COMPRISING SAMEApril 2019March 2022Allow3430YesNo
16346426ARTIFICIAL EYE AND VISUAL AID DEVICEApril 2019February 2022Abandon3321YesNo
16397875SYSTEMS AND METHODS FOR OUTPUT CHANNEL ARCHITECTURES IN IMPLANTABLE PULSE GENERATORSApril 2019July 2022Allow3831YesYes
16396316BIOLOGICAL MARKER AND METHODSApril 2019June 2021Allow2511NoNo
16396230MULTI-MODE ELECTRICAL STIMULATION SYSTEMS AND METHODS OF MAKING AND USINGApril 2019December 2021Allow3141YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BERTRAM, ERIC D.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
6
Examiner Affirmed
3
(50.0%)
Examiner Reversed
3
(50.0%)
Reversal Percentile
79.7%
Higher than average

What This Means

With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
23
Allowed After Appeal Filing
7
(30.4%)
Not Allowed After Appeal Filing
16
(69.6%)
Filing Benefit Percentile
47.6%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 30.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner BERTRAM, ERIC D - Prosecution Strategy Guide

Executive Summary

Examiner BERTRAM, ERIC D works in Art Unit 3792 and has examined 339 patent applications in our dataset. With an allowance rate of 82.9%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 29 months.

Allowance Patterns

Examiner BERTRAM, ERIC D's allowance rate of 82.9% places them in the 57% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by BERTRAM, ERIC D receive 2.34 office actions before reaching final disposition. This places the examiner in the 62% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BERTRAM, ERIC D is 29 months. This places the examiner in the 66% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +11.1% benefit to allowance rate for applications examined by BERTRAM, ERIC D. This interview benefit is in the 45% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 26.6% of applications are subsequently allowed. This success rate is in the 47% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 41.0% of cases where such amendments are filed. This entry rate is in the 64% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 20.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 28% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 72.7% of appeals filed. This is in the 61% percentile among all examiners. Of these withdrawals, 37.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 73% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 52% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

    Relevant MPEP Sections for Prosecution Strategy

    • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
    • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
    • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
    • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
    • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
    • MPEP § 1214.07: Reopening prosecution after appeal

    Important Disclaimer

    Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

    No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

    Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

    Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.